Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
4
100%

Phase Distribution

0

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Other(3)

Detailed Status

unknown3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 24 (100.0%)

Trials by Status

not_yet_recruiting125%
unknown375%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_2

Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger

NCT07569289
unknownphase_2

Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger

NCT06146413
unknownphase_2

Double Trigger in Patients With Low Proportion of Mature Oocytes

NCT04407052
unknownphase_2

Double Trigger in Patients With Low Number of Oocytes Retrieved Per Number of Preovulatory Follicles

NCT04407065

Clinical Trials (4)

Showing 4 of 4 trials
NCT07569289Phase 2

Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger

Not Yet Recruiting
NCT06146413Phase 2

Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger

Unknown
NCT04407052Phase 2

Double Trigger in Patients With Low Proportion of Mature Oocytes

Unknown
NCT04407065Phase 2

Double Trigger in Patients With Low Number of Oocytes Retrieved Per Number of Preovulatory Follicles

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4